Recombinant tmem41aa (UniProt ID: Q502G2) is a 259-amino acid protein (23–281aa) with a molecular weight of ~31.5 kDa . It belongs to the transmembrane protein family and is tagged with a hexahistidine (His) tag at the N-terminus for purification .
| Feature | TMEM41AA (zebrafish) | TMEM41B (human) |
|---|---|---|
| Gene ID | 553803 | 158293 |
| Localization | Endoplasmic reticulum | Endoplasmic reticulum |
| Function | Developmental processes | Autophagy, lipid synthesis |
Recombinant tmem41aa is synthesized using two primary systems:
Post-translational modifications: Preserves native folding and activity .
Applications: Suitable for functional assays requiring mammalian-like processing .
Zebrafish models rely on tmem41aa to study organogenesis due to optical transparency of embryos .
Genetic knockout studies explore its role in lipid metabolism and membrane trafficking .
TMEM41B (human homolog) is implicated in viral entry (e.g., pseudorabies virus) via lipid synthesis regulation .
Functional ambiguity: Limited direct studies on zebrafish tmem41aa; most insights extrapolated from mammalian homologs .
Structural studies: Cryo-EM or X-ray crystallography needed to resolve 3D conformation .
Interactome mapping: Partners like VMP1 (vesicle-associated membrane protein) remain unexplored in zebrafish .
Transmembrane protein 41A-A (tmem41aa) is a protein encoded in the Danio rerio (zebrafish) genome with the UniProt accession number Q502G2. The protein is also known by synonyms including tmem41a, and is associated with gene names si:dkeyp-30d5.3 and zgc:112259 . The full-length protein encompasses amino acids 23-281, with a complete sequence featuring multiple transmembrane domains as indicated by its hydrophobic amino acid composition .
Zebrafish has emerged as a crucial vertebrate model organism, designated as such by the National Institutes of Health, due to several experimental advantages including:
Genetic tractability comparable to Drosophila
Small size and low maintenance requirements
Rapid developmental timeline
Transparent embryos with external development
These characteristics make zebrafish particularly valuable for high-throughput screening approaches and whole-organism studies involving transmembrane proteins like tmem41aa . The protein's importance as a research target stems from its potential role in various cellular pathways and molecular functions, making it relevant for fundamental biological research and potentially for disease modeling studies.
Recombinant tmem41aa requires specific storage and handling protocols to maintain stability and functionality. Based on established guidelines for this protein, researchers should:
Storage Temperature: Store the protein at -20°C for routine use. For extended storage periods, maintain at -20°C or -80°C .
Buffer Composition: The protein is typically supplied in a Tris-based buffer containing 50% glycerol, specifically optimized for tmem41aa stability .
Aliquoting Protocol: To minimize freeze-thaw cycles, divide the stock into working aliquots immediately upon receipt. Working aliquots may be stored at 4°C for up to one week .
Freeze-Thaw Considerations: Repeated freezing and thawing is strongly discouraged as it can compromise protein integrity. Multiple freeze-thaw cycles may lead to protein denaturation, aggregation, and loss of functional activity .
Working Temperature: When performing experiments, maintain the protein on ice when not in use to minimize degradation.
For experimental reproducibility, it's essential to document all handling procedures, including thawing methods, temperature fluctuations, and time at different storage conditions.
Validation of recombinant tmem41aa identity and purity requires a multi-method approach:
SDS-PAGE Analysis: Run the protein on an appropriate percentage gel (typically 10-12%) alongside molecular weight markers. Recombinant tmem41aa should appear at the expected molecular weight, with consideration for any fusion tags (such as His-tags) that may affect migration .
Western Blot Confirmation: Perform immunoblotting using antibodies specific to either tmem41aa or the fusion tag (e.g., anti-His antibody for His-tagged proteins). This confirms both the identity and integrity of the recombinant protein .
Mass Spectrometry Verification: For definitive identification, tryptic digest followed by mass spectrometry analysis can verify the protein sequence against the expected amino acid composition (VFLPPGPQLHKQSHEGETTDAKDGDEPSEMETASSRLKFPSDLDELKEMAELLQFYKTEH TGYVLLLFCSAYLYKQAFAIPGSSFLNILAGALFGTWFGLLLTCVLTTVGATLCFLLSQA FGKHHIVKLFPDKVAmLQKKVEENRSSLFFFLLFLRFFPMSPNWFLNMTSPILNIPVTLF FMAVFIGLMPYNFICVQTGSmLSQISSLDDLFSWSVVLKLLLTACVALLPGALIRKYSTR HLHLDGLETNGLSQNKKNR) .
Circular Dichroism: For structural validation, particularly for transmembrane proteins, circular dichroism can confirm proper protein folding and secondary structure elements.
Functional Assays: Depending on the known functions of tmem41aa, specific activity assays should be employed to verify that the recombinant protein maintains its expected biochemical activity.
A quality validation report should document all these analyses with appropriate controls to ensure experimental reproducibility and reliable interpretation of subsequent experimental results.
Investigating tmem41aa protein interactions in zebrafish requires a multi-faceted experimental approach:
Co-Immunoprecipitation (Co-IP): This technique can identify direct protein-protein interactions with tmem41aa. When working with zebrafish models:
Use anti-tmem41aa antibodies or antibodies against tagged versions (His-tagged recombinant tmem41aa) to pull down protein complexes
Verify interactions using reciprocal Co-IP with antibodies against putative interacting partners
Include appropriate negative controls (IgG, unrelated proteins) to confirm specificity
Proximity Ligation Assays (PLA): This technique allows visualization of protein interactions in situ:
Can be performed on fixed zebrafish tissue sections or cells
Requires specific antibodies against tmem41aa and potential interactors
Provides spatial information about where interactions occur within cells/tissues
Yeast Two-Hybrid (Y2H) Screening:
Clone tmem41aa (or domains of interest) into appropriate Y2H vectors
Screen against zebrafish-specific cDNA libraries
Validate positive interactions using alternative methods
CRISPR-Cas9 Genetic Modification:
Generate tmem41aa knockout zebrafish lines to assess loss-of-function effects
Create transgenic zebrafish expressing tagged tmem41aa (e.g., fluorescent protein fusions)
Analyze phenotypic changes and molecular pathway alterations
Interactome Analysis:
For rigorous research, combining multiple interaction detection methods provides stronger evidence and reduces method-specific artifacts. Documentation of all experimental parameters is essential for reproducibility.
Designing effective SCEDs for tmem41aa functional studies requires careful methodological planning:
Baseline Establishment:
Collect a minimum of 3-5 data points during baseline phases to establish stable pre-intervention measurements
Ensure baseline observations are representative of natural tmem41aa function or expression
Collect multiple parameters simultaneously (e.g., protein expression, localization, associated phenotypes)
Phase Structure:
Implement a reversal design (ABAB) where:
A = baseline condition
B = experimental intervention (e.g., tmem41aa inhibition, overexpression)
This design requires at least four phases to demonstrate experimental control
Alternatively, use multiple baseline designs with replication across at least three conditions (e.g., different tissues, developmental stages, or genetic backgrounds)
Intervention Fidelity:
Ensure consistent application of the intervention
Document intervention parameters (dosage, timing, delivery method)
Verify the intervention directly affects tmem41aa (e.g., through expression analysis)
Data Collection Frequency:
Randomization Component:
Analysis Considerations:
This approach aligns with contemporary SCED standards while adapting to the specific challenges of zebrafish tmem41aa research.
Quantifying tmem41aa expression across developmental stages presents unique methodological challenges that can be addressed through:
Temporal Sampling Strategy:
Establish precise developmental staging criteria (hours post-fertilization, morphological markers)
Implement systematic sampling at key developmental transitions
Include tightly-spaced time points during periods of rapid development
RNA Quantification Methods:
qRT-PCR with stage-specific reference genes for normalization
RNA-Seq for genome-wide context of expression patterns
In situ hybridization for spatial localization of tmem41aa transcripts
Single-cell RNA-Seq to identify cell-type specific expression patterns
Protein Quantification Approaches:
Western blot with densitometry analysis using stage-appropriate loading controls
Mass spectrometry-based quantification for absolute protein amounts
Immunohistochemistry for spatial protein distribution
Live imaging of fluorescently-tagged tmem41aa in transgenic lines
Reference Standards:
Data Normalization Strategies:
Normalize to total protein amount for different sized embryos/larvae
Account for changing cell numbers during development
Consider tissue-specific normalization for organ-focused analyses
Statistical Analysis:
Apply time-series analysis methods appropriate for developmental data
Account for non-independence of sequential developmental stages
Use mixed-effects models to separate individual-level and stage-level variation
This comprehensive approach enables reliable quantification while addressing the biological complexities of developmental expression.
Robust experimental design for tmem41aa research requires multi-level control implementation:
Negative Controls:
Vehicle-only treatments (matching buffer composition without protein)
Irrelevant recombinant proteins of similar size/structure to control for non-specific effects
Non-targeting constructs in genetic manipulation studies
Wild-type zebrafish strains alongside experimental groups
Positive Controls:
Known modulators of pathways involving tmem41aa
Well-characterized phenotypes in relevant tissues/systems
Previously validated interacting partners of tmem41aa
Specificity Controls:
Rescue experiments following knockdown/knockout (using recombinant tmem41aa)
Concentration-response relationships to verify specific effects
Multiple independent methods targeting tmem41aa function
Technical Controls:
Multiple reference genes for qPCR normalization
Loading controls for Western blots
Staining controls for immunohistochemistry/immunofluorescence
Antibody validation (using knockout/knockdown samples)
Biological Replication:
Independent biological replicates (different clutches of embryos)
Experiments performed across different times/days
Verification across multiple zebrafish lines
Developmental Controls:
Precise staging of embryos/larvae
Control for potential developmental delays caused by manipulations
Inclusion of developmental marker genes/proteins
Environmental Controls:
Standardized housing conditions (temperature, light cycles, water quality)
Consistent feeding regimens
Tracking of environmental variables that may influence results
These controls help distinguish specific tmem41aa-related effects from experimental artifacts and natural biological variation.
Designing effective HTS protocols for tmem41aa function requires systematic optimization:
Assay Selection and Development:
Choose endpoints directly linked to tmem41aa function
Develop assays amenable to automation and quantitative readouts
Validate assay performance metrics (Z-factor, signal-to-background ratio, coefficient of variation)
Zebrafish Model Preparation:
Screening Platform Selection:
Sample Size and Layout:
Determine minimum sample size for statistical power
Implement randomized plate layouts to control for position effects
Include internal controls on each plate for normalization
Screening Protocol Optimization:
| Parameter | Consideration | Recommendation |
|---|---|---|
| Developmental stage | Target stage for maximal tmem41aa expression | Stage-specific, based on preliminary expression data |
| Compound concentration | Balance between efficacy and toxicity | 5-point dose series, typically 0.1-30 μM |
| Exposure duration | Time required for phenotype development | 24-72 hours, with multiple observation timepoints |
| Sample number | Statistical power requirements | Minimum n=8 per condition, replicated in independent experiments |
| Controls | Validation of assay performance | Positive, negative, and vehicle controls on each plate |
Data Analysis Pipeline:
Hit Validation Strategy:
This structured approach maximizes the efficiency and reliability of HTS for tmem41aa functional investigation.
Investigating tmem41aa protein-membrane interactions requires specialized experimental design:
Membrane System Selection:
Native membranes (from zebrafish tissues/cells)
Artificial membrane systems (liposomes, bicelles, nanodiscs)
Planar lipid bilayers for electrophysiology
Each system offers tradeoffs between physiological relevance and experimental control
Lipid Composition Considerations:
Match lipid composition to the native environment of tmem41aa
Systematically vary lipid composition to identify specific interactions
Include relevant sterols and phospholipids found in zebrafish membranes
Consider developmental changes in membrane composition
Protein Preparation:
Interaction Analysis Techniques:
Fluorescence-based assays (FRET, anisotropy) for dynamic measurements
Surface plasmon resonance for binding kinetics
Microscopy approaches for membrane localization (TIRF, confocal)
Molecular dynamics simulations to predict interaction sites
Experimental Variables to Control:
| Variable | Impact | Control Method |
|---|---|---|
| pH | Affects protein conformation and charge | Buffer with appropriate pKa for physiological pH |
| Temperature | Influences membrane fluidity and protein dynamics | Maintain at zebrafish physiological temperature (28°C) |
| Ionic strength | Affects electrostatic interactions | Use physiologically relevant salt concentrations |
| Membrane curvature | May alter protein insertion/function | Control liposome size or use supported bilayers |
| Protein:lipid ratio | Critical for proper incorporation | Titrate to determine optimal ranges |
Validation Approaches:
Site-directed mutagenesis of predicted membrane-interacting residues
Competition assays with peptides derived from transmembrane domains
Crosslinking studies to capture transient interactions
Compare wild-type and disease-associated variants
Data Analysis Considerations:
Develop binding models appropriate for membrane proteins
Account for cooperative binding if present
Consider kinetic and thermodynamic parameters separately
Validate with multiple independent techniques
This comprehensive approach addresses the complex nature of transmembrane protein-lipid interactions while maintaining experimental rigor.
Time-series data from tmem41aa expression studies present unique analytical challenges requiring specialized statistical approaches:
Autocorrelation Analysis:
Visual Analysis Methods:
Parametric Time-Series Models:
Autoregressive integrated moving average (ARIMA) models
Account for trend, seasonality, and random variation components
Particularly useful for longer time-series with sufficient data points
Non-Parametric Approaches:
Randomization tests for experimental designs with intervention components
Tau-U analysis for controlling baseline trends and phase overlap
Percentage of non-overlapping data (PND) and related metrics
Single-Case-Specific Methods:
Hierarchical/Multilevel Models:
Account for nested data structures (e.g., cells within tissues, tissues within organisms)
Allow for random effects at multiple levels
Can incorporate covariates such as developmental stage or experimental conditions
Statistical Power Considerations:
Effect Size Calculation:
Standardized mean difference for level changes
Slope/trend effect sizes for rate of change
Non-overlap metrics (NAP, Tau-U) for distribution separation
This comprehensive analytical framework aligns with contemporary standards in single-case experimental design while addressing the specific challenges of tmem41aa expression data .
Effective integration of multi-modal experimental data for tmem41aa characterization requires systematic triangulation approaches:
Cross-Validation Framework:
Establish consistent criteria for evaluating evidence across methods
Weight findings based on methodological rigor and reproducibility
Identify convergent findings that appear across multiple techniques
Multi-Omics Data Integration:
Combine transcriptomic, proteomic, and functional data
Apply pathway analysis tools to position tmem41aa within cellular networks
Utilize visualization tools that allow overlaying different data types
Integration Strategies:
| Data Type | Integration Approach | Software/Tools |
|---|---|---|
| Transcriptomic | Co-expression network analysis | WGCNA, Cytoscape |
| Proteomic | Protein-protein interaction mapping | STRING, BioGRID |
| Phenotypic | Ontology-based annotation and clustering | Zebrafish Phenotype Ontology |
| Structural | Molecular modeling with functional mapping | PyMOL, UCSF Chimera |
| Genetic | Epistasis analysis and genetic interaction mapping | GeneMania, GeneMANIA |
Bayesian Approaches:
Develop Bayesian models that incorporate prior knowledge
Update probability estimates as new evidence emerges
Account for varying levels of uncertainty across experimental approaches
Meta-Analysis Methods:
When multiple similar experiments exist, apply formal meta-analysis
Use fixed or random effects models depending on heterogeneity
Calculate combined effect sizes with confidence intervals
Systems Biology Framework:
Develop mathematical models of pathways involving tmem41aa
Test model predictions with targeted experiments
Iteratively refine models based on new experimental data
Contradiction Resolution Protocol:
Visualization Strategies:
Develop integrated visualizations showing multiple data dimensions
Use consistent color schemes and symbols across data representations
Create interactive visualizations for exploring complex relationships
This structured integration approach provides a comprehensive understanding of tmem41aa function while acknowledging the strengths and limitations of individual experimental methods.
Resolving data contradictions in tmem41aa research requires systematic methodological investigation:
This structured approach transforms contradictions from research obstacles into opportunities for deeper understanding of tmem41aa biology.
Current knowledge gaps and promising research directions for tmem41aa in zebrafish include:
Structural-Functional Relationships:
Detailed structural characterization of transmembrane domains and their specific roles
Structure-guided mutagenesis to identify critical functional residues
Comparative analysis with mammalian orthologs to identify conserved functional domains
Developmental Regulation:
Comprehensive spatiotemporal expression mapping throughout zebrafish development
Regulatory mechanisms controlling tmem41aa expression
Functional significance of expression pattern changes during development
Pathway Integration:
Physiological Functions:
Disease Relevance:
Potential contributions to vertebrate disease states
Development of disease models based on tmem41aa mutations
Exploration of therapeutic approaches targeting tmem41aa pathways
Technological Advancement Needs:
Development of highly specific antibodies for zebrafish tmem41aa
Creation of reporter lines for dynamic visualization of expression
Advanced imaging techniques for tracking tmem41aa localization in vivo
Methodological Improvements:
These research directions will contribute to a comprehensive understanding of tmem41aa biology while addressing current methodological and knowledge limitations in the field.
Translating tmem41aa findings from zebrafish to broader vertebrate biology requires systematic comparative approaches:
Evolutionary Conservation Analysis:
Comprehensive sequence alignment across vertebrate species
Identification of conserved domains and critical residues
Phylogenetic analysis to understand evolutionary relationships
Cross-Species Functional Comparison:
Complementation studies using orthologs from different species
Evaluation of functional conservation in different cellular contexts
Analysis of species-specific interaction partners
Model Translation Framework:
| Translation Level | Approach | Evaluation Metrics |
|---|---|---|
| Molecular | Compare biochemical properties of orthologs | Binding affinities, protein stability, post-translational modifications |
| Cellular | Assess subcellular localization and interactions | Co-localization patterns, interaction networks, trafficking dynamics |
| Physiological | Compare phenotypes in multiple model organisms | Severity, penetrance, tissue specificity of phenotypes |
| Disease relevance | Evaluate mutations in disease contexts | Genotype-phenotype correlations across species |
Comparative Expression Analysis:
Compare expression patterns across developmental stages in multiple species
Identify conserved regulatory elements controlling expression
Analyze tissue-specificity conservation across vertebrates
Translational Experimental Design:
Develop parallel experimental protocols applicable across species
Design experiments that test evolutionary conservation hypotheses
Implement consistent phenotyping approaches across model systems
Integrative Data Resources:
Contribute to and utilize cross-species databases
Develop visualization tools for comparing findings across organisms
Create unified nomenclature and ontologies for cross-species comparisons
Collaborative Research Frameworks:
Establish research consortia focused on multi-species approaches
Standardize methods and reporting for cross-species comparison
Implement data sharing protocols to facilitate integration
Limitations and Constraints:
Acknowledge species-specific differences in interpretation
Consider evolutionary divergence in pathway components
Account for differences in experimental accessibility between models